Levey Advisors provides rigorous, unconflicted equity research to a select group of institutional investors. We operate outside the sell-side consensus — offering analysis built on primary work, not aggregated opinion.
Our approachWe do not publish to maintain relationships or manage corporate access. Every report begins and ends with a clear investment view, supported by primary analysis and independent judgement.
Our research is distributed exclusively to institutional clients under a subscription mandate. We do not offer access to issuers, we do not accept corporate commissions, and we do not participate in deal flow. This structure ensures our analysis remains singular in purpose: to help our clients make better investment decisions.
The result is research that can say what others in the market cannot.
We build from the ground up — channel checks, expert networks, primary data, and original financial modelling. Consensus estimates are a starting point, not a destination.
Levey Advisors carries no corporate relationships, no banking affiliations, and no conflicts of interest. Our coverage universe is determined by investment merit alone.
We write when we have something differentiated to say. Clients receive fewer, higher-conviction notes — not a volume-driven research calendar.
All client relationships and research distribution are handled with strict confidentiality. We do not publish research publicly, market our client list, or disclose mandates.
Our analysts bring deep sector expertise developed across leading buy-side and sell-side institutions. We concentrate coverage where primary research advantage is greatest and where independent analysis is scarcest.
Coverage evolves with client mandate. Enquiries regarding specific sectors or geographies are welcomed.
Enterprise software, semiconductors, and digital infrastructure. Focus on unit economics, competitive moats, and re-rating catalysts.
Banks, asset managers, specialty finance, and insurance. Differentiated balance-sheet modelling and regulatory scenario analysis.
Pharmaceuticals, medtech, and diagnostics. Pipeline valuation, clinical data interpretation, and commercial ramp analysis.
Capital goods, energy transition, and infrastructure. Cycle analysis, pricing power assessment, and long-duration thesis development.
Levey Advisors accepts a limited number of institutional mandates. We do not offer trial access, syndicated products, or conference calls open to a broad audience.
Clients are long-only funds, hedge funds, and family offices who value the quality of analysis over the quantity of coverage — and who understand that unconflicted research requires a different commercial model.
"The most useful research we receive is the research that tells us something we don't already know. That requires independence — of opinion, of process, and of commercial structure."Portfolio Manager, European Long/Short Fund
We welcome introductory conversations with institutional investors. All enquiries are handled personally and in strict confidence.
The best starting point is a brief note on your research needs — we will respond directly and without obligation.